|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7068 | (2006.01) |
| A61K 31/7068 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61K 47/54 | (2017.01) |
| (11) | Patento numeris | 3383407 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16870114.2 |
| Europos patento paraiškos padavimo data | 2016-01-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-12-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2016/050077 |
| Data | 2016-01-25 |
| (87) | Numeris | WO 2017/093993 |
| Data | 2017-06-08 |
| (30) | Numeris | Data | Šalis |
| 201562262428 P | 2015-12-03 | US |
| (72) |
GENGRINOVITCH, Stela , IL
BEN YAKAR, Ruth , IL
|
| (73) |
BioSight Ltd. ,
3 Hayarden Street
Airport City, P.O.Box 1083, Lod 7019802,
IL
|
| (54) | CYTARABINE CONJUGATES FOR CANCER THERAPY |
| CYTARABINE CONJUGATES FOR CANCER THERAPY |